NASDAQ: SLBTHorizon Space Acquisition II Corp Stock
$4.72-1.27 (-21.2%)
Updated Jul 6, 2026
SLBT Price
$4.72
Fair Value Price
N/A
Market Cap
$2.64B
52 Week Low
$3.00
52 Week High
$14.50
P/E
N/A
P/B
1,157.66x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$2.20M
Earnings
$1.31M
Gross Margin
N/A
Operating Margin
-173.85%
Profit Margin
-173.8%
Debt to Equity
0.23
Operating Cash Flow
-$972k
Beta
-0.08
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
SLBT Overview
Horizon Space Acquisition II Corp. aims to achieve strategic business combinations with other companies. This objective can be fulfilled through various transactional structures, including mergers, exchanges of shares, acquisitions of assets, direct purchases of stock, recapitalizations, or other forms of corporate reorganization. The firm was founded in 2023 and maintains its headquarters in New York, New York.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SLBT's potential to beat the market
- SLBT doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important SLBT news, forecast changes, insider trades & much more!
SLBT News
Overview
Due Diligence Score
–
Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SLBT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SLBT is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SLBT is poor value based on its book value relative to its share price (1,157.66x), compared to the US Biotechnology industry average (5.58x)
P/B vs Industry Valuation
SLBT is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SLBT due diligence checks available for Premium users.
Valuation
SLBT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0x
Industry
18.36x
Market
6.94x
SLBT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1,157.66x
Industry
5.58x
SLBT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SLBT's financial health
Profit margin
Revenue
$0.0
Net Income
-$29.1k
Profit Margin
0%
SLBT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SLBT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$39.5M
Liabilities
$39.3M
Debt to equity
-22.05
SLBT's short-term assets ($1.43M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SLBT's short-term assets ($1.43M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SLBT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$215.0k
Investing
$34.1M
Financing
-$33.9M
SLBT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SLBT vs Biotech Stocks
Horizon Space Acquisition II Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.